FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to industrial microbiology, namely to application of strain of Lactobacillus casei, deposited under number I-1518, for obtaining composition for stimulating response of cells-natural killers in adult individual with common respiratory infectious disease, where composition also contains bacteria Lactobacillus bulgaricus and Streptococcus thermophilus.
EFFECT: application of composition, containing Lactobacillus casei I-1518, makes it possible to increase resistance of organism to common respiratory infections, in particular to rhinopharyngitis or laryngitis.
17 cl, 12 tbl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF LACTOBACILLUS CASEI FOR INTENSIFIED PROTECTION INDUCED BY INFLUENZA VACCINATION | 2008 |
|
RU2470994C2 |
| COMPOSITION CONTAINING COMBINATION OF ELDER EXTRACT AND STRAIN L. PARACASEL, L. CASEI, L. BULGARICUS OR S. THERMOPHILICS | 2009 |
|
RU2537185C2 |
| LACTOBACILLUS APPLICATION FOR TREATING VIRAL INFECTIONS | 2006 |
|
RU2440123C2 |
| LACTOBACILLUS APPLICATION FOR TREATING AUTOIMMUNE DISEASES | 2006 |
|
RU2417092C2 |
| METHOD FOR RELIEVING ABDOMINAL MURMUR BY INTRODUCING BACTERIA OF GENUS Bifidobacterium | 2009 |
|
RU2492869C2 |
| METHOD FOR REDUCING ABDOMINAL GIRTH BY ADMINISTERING BACTERIA BIFIDOBACTERIUM | 2008 |
|
RU2491946C2 |
| COMBINATION OF LACTOBACTERIA FOR RELIEF OF IRRITABLE BOWEL SYNDROME AND FOR RELIEF OF OTHER GASTROINTESTINAL DISORDERS | 2019 |
|
RU2809845C2 |
| USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | 2017 |
|
RU2757453C2 |
| NON-VIABLE BACTERIA BIFIDOBACTERIUM BIFIDUM AND THEIR USE | 2019 |
|
RU2800878C2 |
| COMPOSITION FOR RELIEVING ANXIETY AND/OR STRESS | 2020 |
|
RU2815833C2 |
